Lj. Sullivan et al., EFFICACY AND SAFETY OF 0.3-PERCENT CARBOMER GEL COMPARED TO PLACEBO IN PATIENTS WITH MODERATE-TO-SEVERE DRY EYE SYNDROME, Ophthalmology, 104(9), 1997, pp. 1402-1408
Purpose: Carbomer gel is a water-soluble polymeric resin that has been
reported to maintain the tear film in contact with the eye for an ext
ended period. The efficacy and safety of this new artificial tear were
assessed. Methods: A multicenter, single-masked, randomized, placebo-
controlled study was carried out on 123 patients with moderate-to-seve
re dry eyes. The placebo was a mannitol solution with benzalkonium chl
oride 0.008% as preservative. Patients were observed over an 8-week pe
riod, and subjective and objective changes analyzed, compared to a bas
eline of no therapy, after 1 to 7 days washout period from previous me
dication. Results: All primary subjective symptoms decreased significa
ntly in the carbomer gel-treated group compared to the placebo group (
i.e., dryness, discomfort, and foreign body sensation). The carbomer g
el also significantly improved the rose bengal staining score relative
to placebo. When data for the primary subjective efficacy variables w
ere stratified for disease severity, there was a statistically signifi
cant improvement from baseline by day 10 for severely affected patient
s and from day 42 for patients with moderate disease. Secondary subjec
tive symptoms that improved significantly in the tear gel group compar
ed to placebo were photophobia, erythema, tear breakup time, blurry-fi
lmy, dry-sandy sensation, and physician impression. However, no signif
icant improvements in the secondary subjective symptoms of tearing, it
ching, scaling, conjunctival discharge, palpebral conjunctival redness
, bulbar conjunctival redness, conjunctival luster, relief of discomfo
rt, ease of use, and overall acceptability were found in either group
over the baseline scope. In addition, neither carbomer gel nor placebo
improved the baseline fluorescein staining score or the Schirmer test
score. Two patients suffered local allergic reactions to the carbomer
gel or its preservative, which settled on withdrawal of the medicatio
n. Conclusions: Carbomer gel was more efficacious than was placebo in
improving a number of subjective and objective symptoms of moderate-to
-severe dry eye syndrome. The results of this study indicate that carb
omer gel was as safe as was the placebo.